Christopher Simon
2017
In 2017, Christopher Simon earned a total compensation of $9M as President and Chief Executive Officer at Haemonetics.
Compensation breakdown
| Non-Equity Incentive Plan | $698,708 |
|---|---|
| Option Awards | $1,312,552 |
| Salary | $709,615 |
| Stock Awards | $6,205,816 |
| Other | $100,307 |
| Total | $9,026,998 |
Simon received $6.2M in stock awards, accounting for 69% of the total pay in 2017.
Simon also received $698.7K in non-equity incentive plan, $1.3M in option awards, $709.6K in salary and $100.3K in other compensation.
Rankings
In 2017, Christopher Simon's compensation ranked 752nd out of 14,666 executives tracked by ExecPay. In other words, Simon earned more than 94.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 752 out of 14,666 | 95th |
Division Manufacturing | 246 out of 5,770 | 96th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 34 out of 856 | 96th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 18 out of 528 | 97th |
Industry Surgical and Medical Instruments and Apparatus | 12 out of 333 | 96th |
Source: SEC filing on June 12, 2019.
Simon's colleagues
We found one more compensation record of an executive who worked with Christopher Simon at Haemonetics in 2017.
2017
William Burke
Haemonetics
Chief Financial Officer
News
Haemonetics CEO Christopher Simon's 2022 pay rises 1% to $8.7M
June 17, 2022
Haemonetics CEO Christopher Simon's 2021 pay slips 8% to $8.6M
June 17, 2021
Haemonetics CEO Christopher Simon's 2020 pay rises 10% to $9.4M
June 8, 2020
Haemonetics CEO Christopher Simon's 2019 pay rises 9% to $8.6M
June 12, 2019